Asthma Control in Obese Patients
The Effect of Montelukast on Asthma Control in Obese Asthmatic Children and Adolescents
Protocol ID
10-029B
Protocol Description
The purpose of this study is to determine if a standard drug for asthma therapy, montelukast (Singulair) works better in obese versus non-obese asthmatics. We would also like to determine if montelukast affects certain protein levels in the blood and urine to a greater extent in obese as opposed to non-obese asthmatics.
Eligibility Criteria
Obese asthmatic children and adolescents
Primary Investigator(s)
- Sherry Farzan, MD
Contact Information
Sherry Farzan, MD
(516) 622-5060
sfarzan@nshs.edu